asa statement glp-1 Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists Perioperative management of patients taking

Davies MJ, Donnelly R, Barnett AH, Jones S, Nicolay C, Kilcoyne A

Economic damages cover measurable financial losses, including: Medical expenses related to emergency care and follow-up treatment Future medical costs for ongoing care or rehabilitation Lost wages from time missed at work Loss of future earning capacity due to permanent injury Costs for medications, medical equipment, and home care Non-economic damages address the personal impact of the injury, including: Pain and suffering Emotional distress Loss of enjoyment of life Impact on daily activities and relationships Effects of life-altering consequences caused by the injury The long-term impact of delayed treatment or improper discharge can be severe

Drug-drug interaction assessment for therapeutic proteins: guidance for industry

Wong SY, Lee ARYB, Sia AHJ et al (2024) Effects of Glucagon-Like Peptide-1 receptor agonist (GLP-1RA) on cardiac structure and function: A systematic review and meta-analysis of randomized-controlled trials